Oncotelic Therapeutics, Inc. (OTLC)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
94.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $70.0K | — | — | $1.74M | — | — | — | — |
| Operating Income | -$3.19M | -$3.58M | -$6.65M | -$9.72M | -$9.13M | -$7.58M | -$4.31M | -$712.7K | -$13.84M | -$13.76M |
| Net Income | $249.28M | -$4.52M | -$7.90M | $5.09M | -$9.39M | -$9.50M | -$6.64M | -$712.7K | -$13.81M | -$13.65M |
| EPS (Diluted) | $0.59 | $0.01 | $-0.02 | $0.01 | $-0.03 | $-0.11 | — | — | — | — |
| Total Assets | $393.09M | $26.68M | $30.01M | $36.12M | $23.61M | $23.66M | $23.68M | $2.75M | $1.17M | $14.11M |
| Total Liabilities | $131.36M | $19.20M | $18.40M | $16.92M | — | — | — | — | — | — |
| Shareholders' Equity | $262.76M | $8.25M | $12.13M | $19.41M | $7.96M | $11.77M | $16.90M | $2.46M | -$483.6K | $12.50M |
| Cash & Equivalents | — | — | $170.4K | $241.5K | $568.8K | $474.0K | $82.0K | $2.5K | $1.11M | $3.54M |
| Operating Cash Flow | -$1.38M | -$740.3K | -$1.32M | -$1.45M | -$4.43M | -$2.81M | -$2.28M | -$241.0K | -$10.93M | — |
| Shares Outstanding | 442.60M | 407.29M | 399.18M | 391.85M | 375.29M | 90.60M | 84.07M | 6.84M | 26.55M | 26.55M |